Posts Tagged ‘ GDNF ’

Biotech Deal Activity Declines…The Pause that Refreshes?

1
January 14, 2010
Biotech Deal Activity Declines…The Pause that Refreshes?

* MD Becker Partners reporting live from the JP Morgan Healthcare Conference This week, nearly 6,500 registrants gathered in San Francisco, California for the JP Morgan Healthcare Conference to hear 25-minute presentations from 338 life science companies.  For industry executives and investors, the annual event serves as a good barometer for the rest of...
Read More »

Treating Parkinson’s Disease: Investment Opportunities and Challenges

6
August 2, 2009
Treating Parkinson’s Disease: Investment Opportunities and Challenges

Parkinson’s disease is one of the most common of the neurogenerative diseases affecting 1 in 100 people over the age of 60.  Approximately 1.5 million Americans currently suffer from the disease and it is estimated that 60,000 Americans are newly diagnosed each year.  PD is both a chronic and progressive disease. While the...
Read More »